Key result
Genome-wide analysis identified no single or combination of variants causing feline HCM, while transcriptomics revealed 74, 115, and 45 upregulated genes in LV, IVS, and LA tissues of HCM cats.
Why the study?
The genetics of feline HCM are poorly understood, with limited genetic discoveries remaining breed- or family-specific.
Observational (n=180)
The genetic etiology of feline HCM remains largely unknown, but transcriptomics revealed molecular signatures that may help identify novel biomarkers or drug targets.
Hypothesis-generating for feline HCM genetics; extends breed-specific data but requires validation before clinical adoption.
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease in cats, often leading to congestive heart failure, arterial thromboembolism, and sudden cardiac death. The genetics of feline HCM are poorly understood and limited genetic discoveries remain breed- or family-specific. We aimed to identify novel causative or disease-modifying variants in a large cohort of cats reflective of the general cat population. In a second cohort, we sought to characterize transcriptomics differences between HCM-affected cats and healthy controls. DNA was isolated from 138 domestic cats (109 HCM and 29 controls). No single or combination of variants of high, moderate, or modifying impact were identified by genome-wide analysis to cause or modify disease severity of HCM. Several rare high and moderate impact variants in genes associated with human HCM were detected in diseased cats. In a second cohort, left ventricular (LV), interventricular septal (IVS), and left atrial (LA) tissues of 27 HCM-affected and 15 control cats were submitted for stranded mature RNA-sequencing at 50 million reads/sample. A total of 74, 115, and 45 differentially expressed genes (DEGs) were upregulated and 8, 53, and 48 DEGs were downregulated in LV posterior wall, IVS, and LA tissue, respectively, in HCM-affected cats compared to controls. Similar to humans, the genetic etiology of feline HCM remains unknown in a high proportion of cases. Transcriptomics revealed molecular signatures that may help identify novel HCM biomarkers or drug targets in future investigations.
No takes yet. Share an insight, caveat, or question.
Kaplan et al. (2025) conducted an observational in Feline hypertrophic cardiomyopathy (n=180). Hypertrophic cardiomyopathy (HCM) vs. Healthy controls was evaluated on Causative or disease-modifying variants and differentially expressed genes. Genome-wide analysis identified no single or combination of variants causing feline HCM, while transcriptomics revealed 74, 115, and 45 upregulated genes in LV, IVS, and LA tissues of HCM cats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: